Your body establishes metabolic rhythms around consistent medication timing, and disrupting those rhythms undermines the steady-state blood levels you worked weeks to build
The central research question guiding this analysis is: Do GLP-1 agonists represent a genuine game-changing breakthrough in obesity treatment, or are they an overhyped intervention with significant practical limitations that may limit their real-world impact
The analysis spanned data from January 1, 2015, to December 31, 2023
Those Having Trouble With Side Effects From Higher Doses Some folks stop taking GLP-1 drugs because the side effects make it tough
Instead of following the standard titration schedule, where you increase your dose every four weeks until you hit the high maintenance level, microdosers stay at the lowest effective dose for months, or even take less than the starting dose
The stomach injection technique matters for getting this right